Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection

Whereas acute rejection is the main risk factor for the occurrence of chronic rejection, mechanisms in addition to the donor-specific immune response probably contribute to late allograft failure. In this study, we investigated the possible role of hypercholesterolemia in the incidence of chronic ki...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation 2000-08, Vol.70 (3), p.464-472
Hauptverfasser: WISSING, K. M, ABRAMOWICZ, D, BROEDERS, N, VEREERSTRAETEN, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 472
container_issue 3
container_start_page 464
container_title Transplantation
container_volume 70
creator WISSING, K. M
ABRAMOWICZ, D
BROEDERS, N
VEREERSTRAETEN, P
description Whereas acute rejection is the main risk factor for the occurrence of chronic rejection, mechanisms in addition to the donor-specific immune response probably contribute to late allograft failure. In this study, we investigated the possible role of hypercholesterolemia in the incidence of chronic kidney graft loss. By using the actuarial method, we retrospectively analyzed the long-term loss of cadaveric kidney grafts in patients who had a functioning graft at 1 year and had received a transplant and undergone cyclosporin A therapy in our center between 1983 and 1997. As observed previously, patients with acute rejection during the 1st posttransplant year (n=198) had significantly higher actuarial graft loss at 10 years compared with those free of acute rejection (n=244). In patients free of acute rejection at 1 year, hypercholesterolemia (> or =250 mg/dl) had no impact on graft loss at 10 years. On the contrary, in patients with previous acute rejection, those with hypercholesterolemia (n=59) had a higher immunological (36.0% vs. 19.2%; P
doi_str_mv 10.1097/00007890-200008150-00012
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71747248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17677331</sourcerecordid><originalsourceid>FETCH-LOGICAL-p267t-4e43a392b07c3acae38d36d2b47b279cf142f7e6697d82152e7d7608b56a0de03</originalsourceid><addsrcrecordid>eNqFkMlOxDAMhiMEgmF5BZQD4lbI1ro9IsQmIXGB88hNXSbQjSQFzUvwzAQxiCO-_I78-Y9txrgUZ1JUcC5SQFmJTH1npcxFllSqLbaQuTZZIUqxzRZCGJlJrWGP7YfwkpBcA-yyvWRiKlmWC_Z5u57I29XYUYjkk_QOuQscQxitw0gN_3Bxxd1gPWFIz1fXDLTmzx7byLsxBG5x_i7Ua25Xfhyc5Z5eyEY3DqmP99gRnzA6GmL4cZs8vbtxTt_YOdIffsh2WuwCHW30gD1dXz1e3mb3Dzd3lxf32aQKiJkho1FXqhZgNVokXTa6aFRtoFZQ2VYa1QIVRQVNqWSuCBpIR6nzAkVDQh-w0x_fyY9vc1p92btgqetwoDTWEiQYUKb8F5RQAGgtE3i8Aee6p2Y5edejXy9_T52Akw2AwWLXehysC39cLotK5foL5QiR0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17677331</pqid></control><display><type>article</type><title>Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection</title><source>MEDLINE</source><source>Journals@Ovid Ovid Autoload</source><creator>WISSING, K. M ; ABRAMOWICZ, D ; BROEDERS, N ; VEREERSTRAETEN, P</creator><creatorcontrib>WISSING, K. M ; ABRAMOWICZ, D ; BROEDERS, N ; VEREERSTRAETEN, P</creatorcontrib><description>Whereas acute rejection is the main risk factor for the occurrence of chronic rejection, mechanisms in addition to the donor-specific immune response probably contribute to late allograft failure. In this study, we investigated the possible role of hypercholesterolemia in the incidence of chronic kidney graft loss. By using the actuarial method, we retrospectively analyzed the long-term loss of cadaveric kidney grafts in patients who had a functioning graft at 1 year and had received a transplant and undergone cyclosporin A therapy in our center between 1983 and 1997. As observed previously, patients with acute rejection during the 1st posttransplant year (n=198) had significantly higher actuarial graft loss at 10 years compared with those free of acute rejection (n=244). In patients free of acute rejection at 1 year, hypercholesterolemia (&gt; or =250 mg/dl) had no impact on graft loss at 10 years. On the contrary, in patients with previous acute rejection, those with hypercholesterolemia (n=59) had a higher immunological (36.0% vs. 19.2%; P&lt;0.01) and overall (50.0% vs. 25.3%; P&lt;0.01) graft loss at 10 years compared with patients with serum cholesterol &lt;250 mg/dl (n=139). Among patients with 1st year acute rejection, hypercholesterolemia was associated with a significant increase in graft loss in male but not in female recipients. Multivariate analysis confirmed that hypercholesterolemia was an independent risk factor for chronic graft loss in male patients (P&lt;0.05). Hypercholesterolemia is an independent risk factor for kidney graft loss from chronic rejection in male patients with previous acute rejection. Correction of hypercholesterolemia could help to reduce kidney graft loss caused by chronic rejection in this category of patients.</description><identifier>ISSN: 0041-1337</identifier><identifier>EISSN: 1534-6080</identifier><identifier>DOI: 10.1097/00007890-200008150-00012</identifier><identifier>PMID: 10949188</identifier><identifier>CODEN: TRPLAU</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Acute Disease ; Adult ; Biological and medical sciences ; Cholesterol - blood ; Chronic Disease ; cyclosporin A ; Female ; Graft Rejection - etiology ; Humans ; Hypercholesterolemia - blood ; Hypercholesterolemia - complications ; Kidney Transplantation - adverse effects ; Male ; Medical sciences ; Middle Aged ; Retrospective Studies ; Risk Factors ; Sex Factors ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system</subject><ispartof>Transplantation, 2000-08, Vol.70 (3), p.464-472</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1516925$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10949188$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WISSING, K. M</creatorcontrib><creatorcontrib>ABRAMOWICZ, D</creatorcontrib><creatorcontrib>BROEDERS, N</creatorcontrib><creatorcontrib>VEREERSTRAETEN, P</creatorcontrib><title>Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection</title><title>Transplantation</title><addtitle>Transplantation</addtitle><description>Whereas acute rejection is the main risk factor for the occurrence of chronic rejection, mechanisms in addition to the donor-specific immune response probably contribute to late allograft failure. In this study, we investigated the possible role of hypercholesterolemia in the incidence of chronic kidney graft loss. By using the actuarial method, we retrospectively analyzed the long-term loss of cadaveric kidney grafts in patients who had a functioning graft at 1 year and had received a transplant and undergone cyclosporin A therapy in our center between 1983 and 1997. As observed previously, patients with acute rejection during the 1st posttransplant year (n=198) had significantly higher actuarial graft loss at 10 years compared with those free of acute rejection (n=244). In patients free of acute rejection at 1 year, hypercholesterolemia (&gt; or =250 mg/dl) had no impact on graft loss at 10 years. On the contrary, in patients with previous acute rejection, those with hypercholesterolemia (n=59) had a higher immunological (36.0% vs. 19.2%; P&lt;0.01) and overall (50.0% vs. 25.3%; P&lt;0.01) graft loss at 10 years compared with patients with serum cholesterol &lt;250 mg/dl (n=139). Among patients with 1st year acute rejection, hypercholesterolemia was associated with a significant increase in graft loss in male but not in female recipients. Multivariate analysis confirmed that hypercholesterolemia was an independent risk factor for chronic graft loss in male patients (P&lt;0.05). Hypercholesterolemia is an independent risk factor for kidney graft loss from chronic rejection in male patients with previous acute rejection. Correction of hypercholesterolemia could help to reduce kidney graft loss caused by chronic rejection in this category of patients.</description><subject>Acute Disease</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cholesterol - blood</subject><subject>Chronic Disease</subject><subject>cyclosporin A</subject><subject>Female</subject><subject>Graft Rejection - etiology</subject><subject>Humans</subject><subject>Hypercholesterolemia - blood</subject><subject>Hypercholesterolemia - complications</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><issn>0041-1337</issn><issn>1534-6080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlOxDAMhiMEgmF5BZQD4lbI1ro9IsQmIXGB88hNXSbQjSQFzUvwzAQxiCO-_I78-Y9txrgUZ1JUcC5SQFmJTH1npcxFllSqLbaQuTZZIUqxzRZCGJlJrWGP7YfwkpBcA-yyvWRiKlmWC_Z5u57I29XYUYjkk_QOuQscQxitw0gN_3Bxxd1gPWFIz1fXDLTmzx7byLsxBG5x_i7Ua25Xfhyc5Z5eyEY3DqmP99gRnzA6GmL4cZs8vbtxTt_YOdIffsh2WuwCHW30gD1dXz1e3mb3Dzd3lxf32aQKiJkho1FXqhZgNVokXTa6aFRtoFZQ2VYa1QIVRQVNqWSuCBpIR6nzAkVDQh-w0x_fyY9vc1p92btgqetwoDTWEiQYUKb8F5RQAGgtE3i8Aee6p2Y5edejXy9_T52Akw2AwWLXehysC39cLotK5foL5QiR0A</recordid><startdate>20000815</startdate><enddate>20000815</enddate><creator>WISSING, K. M</creator><creator>ABRAMOWICZ, D</creator><creator>BROEDERS, N</creator><creator>VEREERSTRAETEN, P</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20000815</creationdate><title>Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection</title><author>WISSING, K. M ; ABRAMOWICZ, D ; BROEDERS, N ; VEREERSTRAETEN, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p267t-4e43a392b07c3acae38d36d2b47b279cf142f7e6697d82152e7d7608b56a0de03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Acute Disease</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cholesterol - blood</topic><topic>Chronic Disease</topic><topic>cyclosporin A</topic><topic>Female</topic><topic>Graft Rejection - etiology</topic><topic>Humans</topic><topic>Hypercholesterolemia - blood</topic><topic>Hypercholesterolemia - complications</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WISSING, K. M</creatorcontrib><creatorcontrib>ABRAMOWICZ, D</creatorcontrib><creatorcontrib>BROEDERS, N</creatorcontrib><creatorcontrib>VEREERSTRAETEN, P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WISSING, K. M</au><au>ABRAMOWICZ, D</au><au>BROEDERS, N</au><au>VEREERSTRAETEN, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection</atitle><jtitle>Transplantation</jtitle><addtitle>Transplantation</addtitle><date>2000-08-15</date><risdate>2000</risdate><volume>70</volume><issue>3</issue><spage>464</spage><epage>472</epage><pages>464-472</pages><issn>0041-1337</issn><eissn>1534-6080</eissn><coden>TRPLAU</coden><abstract>Whereas acute rejection is the main risk factor for the occurrence of chronic rejection, mechanisms in addition to the donor-specific immune response probably contribute to late allograft failure. In this study, we investigated the possible role of hypercholesterolemia in the incidence of chronic kidney graft loss. By using the actuarial method, we retrospectively analyzed the long-term loss of cadaveric kidney grafts in patients who had a functioning graft at 1 year and had received a transplant and undergone cyclosporin A therapy in our center between 1983 and 1997. As observed previously, patients with acute rejection during the 1st posttransplant year (n=198) had significantly higher actuarial graft loss at 10 years compared with those free of acute rejection (n=244). In patients free of acute rejection at 1 year, hypercholesterolemia (&gt; or =250 mg/dl) had no impact on graft loss at 10 years. On the contrary, in patients with previous acute rejection, those with hypercholesterolemia (n=59) had a higher immunological (36.0% vs. 19.2%; P&lt;0.01) and overall (50.0% vs. 25.3%; P&lt;0.01) graft loss at 10 years compared with patients with serum cholesterol &lt;250 mg/dl (n=139). Among patients with 1st year acute rejection, hypercholesterolemia was associated with a significant increase in graft loss in male but not in female recipients. Multivariate analysis confirmed that hypercholesterolemia was an independent risk factor for chronic graft loss in male patients (P&lt;0.05). Hypercholesterolemia is an independent risk factor for kidney graft loss from chronic rejection in male patients with previous acute rejection. Correction of hypercholesterolemia could help to reduce kidney graft loss caused by chronic rejection in this category of patients.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>10949188</pmid><doi>10.1097/00007890-200008150-00012</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1337
ispartof Transplantation, 2000-08, Vol.70 (3), p.464-472
issn 0041-1337
1534-6080
language eng
recordid cdi_proquest_miscellaneous_71747248
source MEDLINE; Journals@Ovid Ovid Autoload
subjects Acute Disease
Adult
Biological and medical sciences
Cholesterol - blood
Chronic Disease
cyclosporin A
Female
Graft Rejection - etiology
Humans
Hypercholesterolemia - blood
Hypercholesterolemia - complications
Kidney Transplantation - adverse effects
Male
Medical sciences
Middle Aged
Retrospective Studies
Risk Factors
Sex Factors
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
title Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T21%3A09%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypercholesterolemia%20is%20associated%20with%20increased%20kidney%20graft%20loss%20caused%20by%20chronic%20rejection%20in%20male%20patients%20with%20previous%20acute%20rejection&rft.jtitle=Transplantation&rft.au=WISSING,%20K.%20M&rft.date=2000-08-15&rft.volume=70&rft.issue=3&rft.spage=464&rft.epage=472&rft.pages=464-472&rft.issn=0041-1337&rft.eissn=1534-6080&rft.coden=TRPLAU&rft_id=info:doi/10.1097/00007890-200008150-00012&rft_dat=%3Cproquest_pubme%3E17677331%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17677331&rft_id=info:pmid/10949188&rfr_iscdi=true